Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab

British Journal of Haematology

Volumn 153, Issue 6, 2011, Pages 789-791

  Darnige, Luc ^a   de Latour, Régis Peffault ^b,c   Zemori, Laurence ^a   Socié, Gérard ^b,c   Fischer, Anne Marie ^a,c,d   Helley, Dominique ^a,c,d  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Antiphospholid antibodies; Paroxysmal nocturnal haemoglobinuria; Thrombosis; Thrombotic haemolytic anaemias

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; ECULIZUMAB; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79957549513     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08665.x     Document Type: Letter

References (4)

1. Dragoni, F., Iori, A.P., Pignoloni, P., Minotti, C., Chiarotti, F., Mazzucconi, M.G., Mengarelli, A., Arcese, W., Foa, R. & Avvisati, G. (2010) Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study. British Journal of Haematology, 150, 492-493.
2. Helley, D., Peffault de Latour, R., Porcher, R., Rodrigues, C.A., Galy-Fauroux, I., Matheron, J., Duval, A., Schved, J.F., Fischer, A.M. & Socié, G; on behalf of the French Society of Hematology. (2010) Evaluation of hemostasis and endothelial dysfunction in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab. Haematologica, 95, 574-580.
3. Hillmen, P., Muus, P., Dührsen, U., Risitano, A.M., Schubert, J., Luzzatto, L., Schrezenmeier, H., Szer, J., Brodsky, R.A., Hill, A., Socié, G., Bessler, M., Rollins, S.A., Bell, L., Rother, R.P. & Young, N.S. (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood, 110, 4123-4128.
4. Pengo, V., Tripodi, A., Reber, G., Rand, J.H., Ortel, T., Galli, M. & de Groot, P.G. (2009) Update of the guidelines for lupus anticoagulant detection. Journal of Thrombosis and Haemostasis, 7, 1737-1740.